Academician
BURÇİN KAYMAZ
PROFESÖR
EGE ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyoloji
A quick look at recorded outputs — details below.
- Articles 66
- Projects 0
- Books 11
- Proceedings 132
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
20
Q2
22
Q3
13
Q4
12
WoS (JCR)
Q1
4
Q2
15
Q3
23
Q4
26
TR Index
20
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
2
Avg percentile
50.9%
Top 1% share
0.0%
Top 10% share
2.9%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2025 Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives YÖKSİS SJR Q3 JCR Q3 OpenAlex top 10% OpenAlex 92.1%
- 2024 Investigating the Effects of a Synthetic Cannabinoid on the Pathogenesis of Leukemia and Leukemic Stem Cells: A New Therapeutic Approach YÖKSİS JCR Q2 OpenAlex 59.2%
- 2024 The Roles of the Golgi in Various Diseases YÖKSİS TR Index JCR Q4 OpenAlex 46.3%
- 2024 Nilotinib Exerts a Therapeutic Approach via JAK/STAT Pathway and Cytokine Network in Chronic Myeloid Leukemia Cells YÖKSİS TR Index OpenAlex 3.8%
- 2024 Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells YÖKSİS SJR Q2 JCR Q4 OpenAlex 65.2%
- 2023 STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.2%
- 2022 Importance of p53 gene polymorphisms in myelodysplastic syndrome disease YÖKSİS TR Index OpenAlex 8.0%
- 2022 Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 55.2%
- 2022 HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents’ combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.5%
- 2022 Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia YÖKSİS SJR Q2 JCR Q3 OpenAlex 56.8%
- 2022 Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.8%
- 2019 Effects of Rituximab on JAK-STAT and NF-κB signaling pathways in acute lymphoblastic leukemia and chronic lymphocytic leukemia YÖKSİS SJR Q4 JCR Q4 OpenAlex 54.7%
- 2018 Matrine induced G0/G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL) cells YÖKSİS SJR Q3 JCR Q4 OpenAlex 81.7%
- 2018 CRISPR/Cas9 Age in Genome Editing and Leukemia Applications YÖKSİS OpenAlex 47.2%
- 2017 TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 1.9%
- 2017 Cystic Fibrosis Mutation Detection with SPR Biosensor in Real Samples via Multiple Surfaces Binding Method YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.4%
- 2017 Determining expression of miRNAs that potentially regulateSTAT5A and 5B in dasatinib-sensitive K562 cells YÖKSİS SJR Q3 JCR Q4 OpenAlex 18.5%
- 2017 From the Immune Response to the Genome Design CRISPR-Cas9 System: Review YÖKSİS SJR Q4 JCR Q4 OpenAlex 55.5%
- 2016 Effects of flavopiridol on critical regulation pathways of CD133high CD44high lung cancer stem cells YÖKSİS SJR Q2 JCR Q2 OpenAlex 68.4%
- 2016 miR 15a enhances the anticancer effects of cisplatin in the resistant non small cell lung cancer cells YÖKSİS SJR Q1 JCR Q2 OpenAlex 74.3%